|
⚲
|
| Transcardiac Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001464911 |
| Sale | 2009-07-24 ($3.0 M Offered, $0.2 M Sold) |
| Fund | |
| Phone | 4048164520 |
| Address | 3355 Lenox Road NE Suite 415 Atlanta, 30326 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Michael Fowler | |
| Larry Hall | |
| Wayne Alexander | |
| Lina Lattouf | |
| David Smith | |
| Ahmed Zaki | |
| Omar Lattouf | |
| Russ Medford |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Adams Street 2025 Global Fund LP
✚
|
0.0 | |
|
Adapt Capital Operations Flagship Fund, LP
✚
|
0.0 | |
|
Adaptor Capital Growth & Opportunity Fund L.P.
✚
|
0.0 | |
|
Ad Astra Integrity Measurement Systems, Inc.
✚
|
0.0 | |
|
ADB International Group, Inc.
✚
|
0.0 | |
|
A-DCI-13-Fund, a series of Abstract Ventures Special Opportu
✚
|
0.0 | |
|
A-DEB-17-Fund, a series of AX-LE-Funds, LLC
✚
|
0.0 | |
|
Adelberg Kenneth
✚
|
0.0 | |
|
Adelgren Paul W
✚
|
0.0 | |
|
Adams Street 2025 Direct Growth Equity Fund LP
✚
|
0.0 |